Curus has a unique approach and a multi-pronged platform to improve the quality of life for a neurodiverse population.

A screening tool that utilises a proprietary algorithm provides unique insights and analytics.

Clinical studies based on Artificial Intelligence (AI) that rank pharmacological agents incorporating a novel approach complete the platform.

Together, these tools provide first-in-class, targeted screening and clinical rigour to Autism Spectrum Disorder.